Abstract
Objective
Urinary leukotriene E4 (U-LTE4) concentrations are significantly elevated in patients with aspirin-intolerant asthma (AIA). However, the relationship between the clinicopathogenetic features of eosinophilic rhinosinusitis and U-LTE4 concentration remains unknown. Here we examined the relationship between U-LTE4 level and eosinophil in chronic rhinosinusitis.Methods
We measured the U-LTE4 concentrations and eosinophil counts in ethmoidal and maxillary sinuses and peripheral blood in 30 asthmatic patients (including 15 AIA patients).Results
Eosinophil counts in ethmoidal sinuses and peripheral blood were markedly higher in asthmatic patients than in controls. Although there were no significant differences between eosinophil counts in maxillary and ethmoidal sinuses for ATA group, eosinophil counts were higher in ethmoidal sinus compared to that in maxillary sinus in the AIA group (P<.05). Eosinophil counts were higher in the maxillary than in ethmoidal sinuses for control patients (P<.05). Despite low correlation between eosinophil counts in peripheral blood and eosinophil counts in maxillary sinus (rs=0.4323, P<.001), moderate correlation was observed between eosinophil counts in peripheral blood and eosinophil counts in ethmoidal sinus (rs=0.5249, P<.0001). Basal U-LTE4 concentrations were higher in AIA patients than in those with aspirin-tolerant asthma. Despite low correlation between eosinophil counts and U-LTE4 concentration in maxillary sinus (rs=0.3849, P<.01), moderate correlation was observed between eosinophil counts and U-LTE4 concentrations in ethmoidal sinus (rs=0.4736, P<.001).Conclusion
We describe the differences in U-LTE4 and other parameters in AIA compared to ATA, and correlation among parameters. We demonstrate that eosinophil-dominant inflammation starts in ethmoidal sinus clinicopathogenetically in CRS with asthma. U-LTE4 concentration was not exclusively associated with eosinophil counts in ethmoidal sinus. Eosinophils in ethmoidal sinus may be a major production site for CysLTs, particularly in AIA. CRS with AIA is assumed to be characterized by leukotriene-eosinophil cross-interaction in ethmoidal sinus.References
Articles referenced by this article (21)
Eosinophilic sinusitis
JIBI INKOKA TEMBO 2001
Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma.
J Allergy Clin Immunol, (2):342-349 2003
MED: 12589355
Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects.
Am J Respir Crit Care Med, (1):90-96 1996
MED: 8542168
Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways.
Am J Respir Crit Care Med, (5):1384-1389 1997
MED: 9372649
Leukotriene C4 elimination and metabolism in man.
J Allergy Clin Immunol, (1 Pt 1):3-9 1990
MED: 2299103
The excretion of leukotriene E4 into urine following inhalation of leukotriene D4 by human individuals.
Biochem Biophys Res Commun, (2):864-868 1987
MED: 3689376
Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.
J Allergy Clin Immunol, (5 Pt 1):643-651 1995
MED: 7499681
Urinary leukotriene E4 levels during early and late asthmatic responses.
J Allergy Clin Immunol, (2):211-220 1990
MED: 2166758
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.
Rhinology, (1):1-12 2012
MED: 22469599
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
Am Rev Respir Dis 1987
Show 10 more references (10 of 21)
Citations & impact
Impact metrics
Article citations
Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis.
Curr Allergy Asthma Rep, 22(12):209-229, 14 Nov 2022
Cited by: 3 articles | PMID: 36374376 | PMCID: PMC9732072
Review Free full text in Europe PMC
Expression of COX-1, COX-2, 5-LOX and CysLT 2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease.
Allergy Asthma Clin Immunol, 15:83, 26 Dec 2019
Cited by: 0 articles | PMID: 31889962 | PMCID: PMC6933683
Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria.
Allergy, 74(6):1135-1144, 06 Feb 2019
Cited by: 11 articles | PMID: 30667070
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
J Allergy Clin Immunol, 113(2):277-283, 01 Feb 2004
Cited by: 56 articles | PMID: 14767442
Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
Eur Ann Allergy Clin Immunol, 38(1):20-23, 01 Jan 2006
Cited by: 11 articles | PMID: 16544584
A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma.
Clin Exp Allergy, 32(10):1484-1490, 01 Oct 2002
Cited by: 37 articles | PMID: 12372129
Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites.
Allergol Int, 61(3):393-403, 25 May 2012
Cited by: 19 articles | PMID: 22627848
Review